ΙΝΟΜΎΩΜΑ ΦΥΣΙΚΗ ΑΝΤΙΜΕΤΩΠΙΣΗ
Παραπομπές
1. October 3, 2013 N Engl J Med 2013; 369:1344-1355 DOI: 10.1056/NEJMra1209993, Uterine Fibroids List of authors. Serdar E. Bulun, M.D.
https://www.nejm.org/doi/10.1056/NEJMra1209993?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
2. Drayer SM, Catherino WH. Prevalence, morbidity, and current medical management of uterine leiomyomas. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 2015 Nov;131(2):117-122. DOI: 10.1016/j.ijgo.2015.04.051. PMID: 26275638.
http://europepmc.org/article/MED/26275638
3. Practice Committee of the American Society for Reproductive Medicine. Electronic address: [email protected]; Practice Committee of the American Society for Reproductive Medicine. Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertil Steril. 2017 Sep;108(3):416-425. doi: 10.1016/j.fertnstert.2017.06.034. PMID: 28865538.
https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/practice-guidelines/for-non-members/removal_of_myomas_in_asymptomatic_patients_to_improve_infertlity_and-or_reduce_miscarriage_rate.pdf
4. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003 Jan;188(1):100-7. doi: 10.1067/mob.2003.99. PMID: 12548202.
https://pubmed.ncbi.nlm.nih.gov/12548202/
5. April 23, 2015 N Engl J Med 2015; 372:1646-1655 DOI: 10.1056/NEJMcp1411029, Uterine Fibroids List of authors. Elizabeth A. Stewart, M.D.
https://www.nejm.org/doi/10.1056/NEJMcp1411029
6. Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017 Sep;124(10):1501-1512. doi: 10.1111/1471-0528.14640. Epub 2017 May 13. PMID: 28296146.
https://pubmed.ncbi.nlm.nih.gov/28296146/
7. Uterine Fibroid Uterine fibroids (UFs) are the most common benign tumor which threaten 70%–80% of women during their reproductive age. From: Encyclopedia of Reproduction (Second Edition), 2018
https://www.sciencedirect.com/topics/medicine-and-dentistry/uterine-fibroid
8. Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012 Mar;206(3):211.e1-9. doi: 10.1016/j.ajog.2011.12.002. Epub 2011 Dec 11. PMID: 22244472; PMCID: PMC3292655.
https://pubmed.ncbi.nlm.nih.gov/22244472/
9. Soliman AM, Yang H, Du EX, Kelkar SS, Winkel C. The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013. Am J Obstet Gynecol. 2015 Aug;213(2):141-60. doi: 10.1016/j.ajog.2015.03.019. Epub 2015 Mar 11. PMID: 25771213.
https://pubmed.ncbi.nlm.nih.gov/25771213/
10. De La Cruz MS, Buchanan EM. Uterine Fibroids: Diagnosis and Treatment. Am Fam Physician. 2017 Jan 15;95(2):100-107. PMID: 28084714.
https://pubmed.ncbi.nlm.nih.gov/28084714/
11. Ghant MS, Sengoba KS, Recht H, Cameron KA, Lawson AK, Marsh EE. Beyond the physical: a qualitative assessment of the burden of symptomatic uterine fibroids on women's emotional and psychosocial health. J Psychosom Res. 2015 May;78(5):499-503. doi: 10.1016/j.jpsychores.2014.12.016. Epub 2015 Feb 2. PMID: 25725565.
https://www.sciencedirect.com/science/article/abs/pii/S0022399914004528?via%3Dihub
12. Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020 Apr;149(1):3-9. doi: 10.1002/ijgo.13102. Epub 2020 Feb 17. PMID: 31960950.
https://deepblue.lib.umich.edu/bitstream/handle/2027.42/154526/ijgo13102.pdf?sequence=1&isAllowed=y
https://pubmed.ncbi.nlm.nih.gov/31960950/
13. Fu Y, Fan Y, Fan W, Lv Y, Ai S, Yu C. Efficacy and safety of traditional Chinese herbal formula combined with western medicine for uterine fibroid: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2020 Sep 4;99(36):e22039. doi: 10.1097/MD.0000000000022039. PMID: 32899062; PMCID: PMC7478476.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478476/
14. Jie Lu, Jing Tian, Li Zhou, Lijun Meng, Sitan Chen, Changyang Ma, Jinmei Wang, Zhenhua Liu, Changqin Li, Wenyi Kang, "Phytochemistry and Biological Activities of Poria", Journal of Chemistry, vol. 2021, Article ID 6659775, 20 pages, 2021. https://doi.org/10.1155/2021/6659775
https://www.hindawi.com/journals/jchem/2021/6659775/
15. Katherine E Hartmann, Digna R Velez Edwards, David A Savitz, Michele L Jonsson-Funk, Pingsheng Wu, Alexandra C Sundermann, Donna D Baird, Prospective Cohort Study of Uterine Fibroids and Miscarriage Risk, American Journal of Epidemiology, Volume 186, Issue 10, 15 November 2017, Pages 1140–1148, https://doi.org/10.1093/aje/kwx062https://academic.oup.com/aje/article/186/10/1140/3859593
16. Freytag D, Günther V, Maass N, Alkatout I. Uterine Fibroids and Infertility. Diagnostics (Basel). 2021 Aug 12;11(8):1455. doi: 10.3390/diagnostics11081455. PMID: 34441389; PMCID: PMC8391505.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391505/
17. American Society for Reproductive Medicine, Fibroids and Fertility, 2015
https://www.reproductivefacts.org/news-and-publications/patient-fact-sheets-and-booklets/documents/fact-sheets-and-info-booklets/fibroids-and-fertility/
18. Veeresham C. Natural products derived from plants as a source of drugs. J Adv Pharm Technol Res. 2012 Oct;3(4):200-1. doi: 10.4103/2231-4040.104709. PMID: 23378939; PMCID: PMC3560124.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560124/
19. Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of Natural Products. 2012 Mar;75(3):311-335. DOI: 10.1021/np200906s. PMID: 22316239; PMCID: PMC3721181.
https://europepmc.org/article/PMC/3721181
20. Carter GT. Natural products and Pharma 2011: strategic changes spur new opportunities. Natural Product Reports. 2011 Oct;28(11):1783-1789. DOI: 10.1039/c1np00033k. PMID: 21909580.
http://europepmc.org/article/MED/21909580
21. Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. 2018 Jan;46:3-11. doi: 10.1016/j.bpobgyn.2017.09.004. Epub 2017 Oct 1. PMID: 29054502.
https://pubmed.ncbi.nlm.nih.gov/29054502/
22. Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). BMJ Clinical Evidence. 2015 Jun;2015:0814. PMID: 26032466; PMCID: PMC4451527.
https://europepmc.org/article/MED/26032466
23. Wise LA, Laughlin-Tommaso SK. Epidemiology of Uterine Fibroids: From Menarche to Menopause. Clinical Obstetrics and Gynecology. 2016 Mar;59(1):2-24. DOI: 10.1097/grf.0000000000000164. PMID: 26744813; PMCID: PMC4733579.
https://europepmc.org/article/MED/26744813
24. Venkatesh SS, Ferreira T, Benonisdottir S, et al. Obesity and risk of female reproductive conditions: A Mendelian randomisation study. Plos Medicine. 2022 Feb;19(2):e1003679. DOI: 10.1371/journal.pmed.1003679. PMID: 35104295; PMCID: PMC8806071.
https://europepmc.org/article/MED/35104295
25. Expert Panel on GYN and OB Imaging; Ascher SM, Wasnik AP, Robbins JB, Adelman M, Brook OR, Feldman MK, Jones LP, Knavel Koepsel EM, Patel-Lippmann KK, Patlas MN, VanBuren W, Maturen KE. ACR Appropriateness Criteria® Fibroids. J Am Coll Radiol. 2022 Nov;19(11S):S319-S328. doi: 10.1016/j.jacr.2022.09.019. PMID: 36436959.
https://pubmed.ncbi.nlm.nih.gov/36436959/
26. Templeman C, Marshall SF, Clarke CA, et al. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertility and Sterility. 2009 Oct;92(4):1436-1446. DOI: 10.1016/j.fertnstert.2008.08.074. PMID: 19019355; PMCID: PMC2765807.
https://europepmc.org/article/PMC/2765807
1. October 3, 2013 N Engl J Med 2013; 369:1344-1355 DOI: 10.1056/NEJMra1209993, Uterine Fibroids List of authors. Serdar E. Bulun, M.D.
https://www.nejm.org/doi/10.1056/NEJMra1209993?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
2. Drayer SM, Catherino WH. Prevalence, morbidity, and current medical management of uterine leiomyomas. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 2015 Nov;131(2):117-122. DOI: 10.1016/j.ijgo.2015.04.051. PMID: 26275638.
http://europepmc.org/article/MED/26275638
3. Practice Committee of the American Society for Reproductive Medicine. Electronic address: [email protected]; Practice Committee of the American Society for Reproductive Medicine. Removal of myomas in asymptomatic patients to improve fertility and/or reduce miscarriage rate: a guideline. Fertil Steril. 2017 Sep;108(3):416-425. doi: 10.1016/j.fertnstert.2017.06.034. PMID: 28865538.
https://www.asrm.org/globalassets/asrm/asrm-content/news-and-publications/practice-guidelines/for-non-members/removal_of_myomas_in_asymptomatic_patients_to_improve_infertlity_and-or_reduce_miscarriage_rate.pdf
4. Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003 Jan;188(1):100-7. doi: 10.1067/mob.2003.99. PMID: 12548202.
https://pubmed.ncbi.nlm.nih.gov/12548202/
5. April 23, 2015 N Engl J Med 2015; 372:1646-1655 DOI: 10.1056/NEJMcp1411029, Uterine Fibroids List of authors. Elizabeth A. Stewart, M.D.
https://www.nejm.org/doi/10.1056/NEJMcp1411029
6. Stewart EA, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017 Sep;124(10):1501-1512. doi: 10.1111/1471-0528.14640. Epub 2017 May 13. PMID: 28296146.
https://pubmed.ncbi.nlm.nih.gov/28296146/
7. Uterine Fibroid Uterine fibroids (UFs) are the most common benign tumor which threaten 70%–80% of women during their reproductive age. From: Encyclopedia of Reproduction (Second Edition), 2018
https://www.sciencedirect.com/topics/medicine-and-dentistry/uterine-fibroid
8. Cardozo ER, Clark AD, Banks NK, Henne MB, Stegmann BJ, Segars JH. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol. 2012 Mar;206(3):211.e1-9. doi: 10.1016/j.ajog.2011.12.002. Epub 2011 Dec 11. PMID: 22244472; PMCID: PMC3292655.
https://pubmed.ncbi.nlm.nih.gov/22244472/
9. Soliman AM, Yang H, Du EX, Kelkar SS, Winkel C. The direct and indirect costs of uterine fibroid tumors: a systematic review of the literature between 2000 and 2013. Am J Obstet Gynecol. 2015 Aug;213(2):141-60. doi: 10.1016/j.ajog.2015.03.019. Epub 2015 Mar 11. PMID: 25771213.
https://pubmed.ncbi.nlm.nih.gov/25771213/
10. De La Cruz MS, Buchanan EM. Uterine Fibroids: Diagnosis and Treatment. Am Fam Physician. 2017 Jan 15;95(2):100-107. PMID: 28084714.
https://pubmed.ncbi.nlm.nih.gov/28084714/
11. Ghant MS, Sengoba KS, Recht H, Cameron KA, Lawson AK, Marsh EE. Beyond the physical: a qualitative assessment of the burden of symptomatic uterine fibroids on women's emotional and psychosocial health. J Psychosom Res. 2015 May;78(5):499-503. doi: 10.1016/j.jpsychores.2014.12.016. Epub 2015 Feb 2. PMID: 25725565.
https://www.sciencedirect.com/science/article/abs/pii/S0022399914004528?via%3Dihub
12. Giuliani E, As-Sanie S, Marsh EE. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020 Apr;149(1):3-9. doi: 10.1002/ijgo.13102. Epub 2020 Feb 17. PMID: 31960950.
https://deepblue.lib.umich.edu/bitstream/handle/2027.42/154526/ijgo13102.pdf?sequence=1&isAllowed=y
https://pubmed.ncbi.nlm.nih.gov/31960950/
13. Fu Y, Fan Y, Fan W, Lv Y, Ai S, Yu C. Efficacy and safety of traditional Chinese herbal formula combined with western medicine for uterine fibroid: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2020 Sep 4;99(36):e22039. doi: 10.1097/MD.0000000000022039. PMID: 32899062; PMCID: PMC7478476.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478476/
14. Jie Lu, Jing Tian, Li Zhou, Lijun Meng, Sitan Chen, Changyang Ma, Jinmei Wang, Zhenhua Liu, Changqin Li, Wenyi Kang, "Phytochemistry and Biological Activities of Poria", Journal of Chemistry, vol. 2021, Article ID 6659775, 20 pages, 2021. https://doi.org/10.1155/2021/6659775
https://www.hindawi.com/journals/jchem/2021/6659775/
15. Katherine E Hartmann, Digna R Velez Edwards, David A Savitz, Michele L Jonsson-Funk, Pingsheng Wu, Alexandra C Sundermann, Donna D Baird, Prospective Cohort Study of Uterine Fibroids and Miscarriage Risk, American Journal of Epidemiology, Volume 186, Issue 10, 15 November 2017, Pages 1140–1148, https://doi.org/10.1093/aje/kwx062https://academic.oup.com/aje/article/186/10/1140/3859593
16. Freytag D, Günther V, Maass N, Alkatout I. Uterine Fibroids and Infertility. Diagnostics (Basel). 2021 Aug 12;11(8):1455. doi: 10.3390/diagnostics11081455. PMID: 34441389; PMCID: PMC8391505.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391505/
17. American Society for Reproductive Medicine, Fibroids and Fertility, 2015
https://www.reproductivefacts.org/news-and-publications/patient-fact-sheets-and-booklets/documents/fact-sheets-and-info-booklets/fibroids-and-fertility/
18. Veeresham C. Natural products derived from plants as a source of drugs. J Adv Pharm Technol Res. 2012 Oct;3(4):200-1. doi: 10.4103/2231-4040.104709. PMID: 23378939; PMCID: PMC3560124.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560124/
19. Newman DJ, Cragg GM. Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of Natural Products. 2012 Mar;75(3):311-335. DOI: 10.1021/np200906s. PMID: 22316239; PMCID: PMC3721181.
https://europepmc.org/article/PMC/3721181
20. Carter GT. Natural products and Pharma 2011: strategic changes spur new opportunities. Natural Product Reports. 2011 Oct;28(11):1783-1789. DOI: 10.1039/c1np00033k. PMID: 21909580.
http://europepmc.org/article/MED/21909580
21. Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F. Epidemiology and Risk Factors of Uterine Fibroids. Best Pract Res Clin Obstet Gynaecol. 2018 Jan;46:3-11. doi: 10.1016/j.bpobgyn.2017.09.004. Epub 2017 Oct 1. PMID: 29054502.
https://pubmed.ncbi.nlm.nih.gov/29054502/
22. Lethaby A, Vollenhoven B. Fibroids (uterine myomatosis, leiomyomas). BMJ Clinical Evidence. 2015 Jun;2015:0814. PMID: 26032466; PMCID: PMC4451527.
https://europepmc.org/article/MED/26032466
23. Wise LA, Laughlin-Tommaso SK. Epidemiology of Uterine Fibroids: From Menarche to Menopause. Clinical Obstetrics and Gynecology. 2016 Mar;59(1):2-24. DOI: 10.1097/grf.0000000000000164. PMID: 26744813; PMCID: PMC4733579.
https://europepmc.org/article/MED/26744813
24. Venkatesh SS, Ferreira T, Benonisdottir S, et al. Obesity and risk of female reproductive conditions: A Mendelian randomisation study. Plos Medicine. 2022 Feb;19(2):e1003679. DOI: 10.1371/journal.pmed.1003679. PMID: 35104295; PMCID: PMC8806071.
https://europepmc.org/article/MED/35104295
25. Expert Panel on GYN and OB Imaging; Ascher SM, Wasnik AP, Robbins JB, Adelman M, Brook OR, Feldman MK, Jones LP, Knavel Koepsel EM, Patel-Lippmann KK, Patlas MN, VanBuren W, Maturen KE. ACR Appropriateness Criteria® Fibroids. J Am Coll Radiol. 2022 Nov;19(11S):S319-S328. doi: 10.1016/j.jacr.2022.09.019. PMID: 36436959.
https://pubmed.ncbi.nlm.nih.gov/36436959/
26. Templeman C, Marshall SF, Clarke CA, et al. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertility and Sterility. 2009 Oct;92(4):1436-1446. DOI: 10.1016/j.fertnstert.2008.08.074. PMID: 19019355; PMCID: PMC2765807.
https://europepmc.org/article/PMC/2765807
Επιστροφή στο πλήρες κείμενο
